Sandoz reaches $469 mln settlement with US states in generic drug antitrust case
MLex Summary: Sandoz reached a $469 million settlement with a coalition of 43 attorneys general to resolve claims that it conspired to artificially inflate generic drug prices and reduce competition, Connecticut...To view the full article, register now.
Already a subscriber? Click here to view full article